Hana Biosciences, Inc. (NASDAQ: HNAB), a South San Francisco, CA-based biopharmaceutical company, is focused on the acquisition, development and commercialization of novel products to strengthen the foundation of cancer care. The company is dedicated to creating value by accelerating the development of lead product candidates, building a best-in-class team, expanding its pipeline, and nurturing a unique company culture. For further information, visit the Company’s web site at www.hanabiosciences.com.
- 17 years ago
QualityStocks
Hana Biosciences, Inc. (NASDAQ: HNAB)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Demonstrates DefendAir Counter-UAS System at Israel Defense Ministry Event
ParaZero Technologies (NASDAQ: PRZO), an aerospace defense company focused on autonomous solutions for manned and…
-
QualityStocksNewsBreaks – GlobalTech Corp. (OTC: GLTK) Names D. Boral Capital as Strategic Advisor for Planned Moda in Pelle Acquisition
GlobalTech (OTC: GLTK), a U.S.-headquartered technology holding company focused on artificial intelligence, big data and…
-
QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Taps Hockey Hall of Famer Jeremy Roenick to Advise International NIL Exchange Initiative
Datavault AI (NASDAQ: DVLT), a provider of patented agentic AI platforms for data observation, valuation…